APP and Alzheimer disease: Finally, in contrary to previously published data indicating the benefit of clathrin‐mediated endocytosis inhibition in AD 72, 73, we find that AP‐2 deletion in neurons facilitates amyloidogenic APP processing and causes synaptic dysfunction (Figs 4 and 5).